BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 9, 2001
View Archived Issues
Protalex completes preclinical studies with new arthritis pharmaceutical
Read More
CREB-based drugs enter animal testing for improving memory
Read More
InKine expands marketing effort for oral purgative preparation to Europe
Read More
Pangene's DNA repair protein inhibitors reverse resistance in human cancers
Read More
Company Profile: EyeTech Pharmaceuticals
Read More
Schering AG acquires rights to Refludan from Aventis
Read More
Research on promising antiobesity agents presented at NAASO meeting
Read More
FAUC-179 discovered at German university as potent and selective D4 partial agonist
Read More
Potent, selective, orally bioavailable aggrecanase inhibitor discovered at DuPont
Read More
New study finds chromium picolinate plus biotin controls blood sugar levels in type 2 diabetics
Read More
GW-3333: an oral TACE/MMP inhibitor with good activity in chronic arthritis
Read More
Genmab and Immunex to codevelop antibody therapeutics for lymphoma
Read More
FDA grants orphan drug designation to Celgene's Revimid for multiple myeloma
Read More
New triple therapy for H. pylori eradication submitted for approval on two fronts
Read More
AMDL acquires combination immunogene therapy technology
Read More
Studies in transgenic mice demonstrate positive effects of AMPAkines in ADHD
Read More
ABX-CBL promising for the management of GVHD according to phase II trial
Read More
New adenosine A2A receptor agonists reported to be particularly useful in respiratory disorders
Read More
Tularik designs LXR receptor modulators and discusses possible uses thereof
Read More
Marine sponge-derived and synthetic antitumor compounds patented by Pharma Mar
Read More
GSK developing inhibitors of Lp-PLA2 for atherosclerosis
Read More
Antiviral pyrazine derivatives in the Toyama pipeline
Read More
Potential treatments for Alzheimer's disease recently presented by DuPont
Read More
Yamanouchi patents new series of antitumor agents
Read More